Zydus Lifesciences Ltd. | Large-cap | Healthcare
₹974.75
1.06%
| Zydus Lifesciences Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 225.7B
Gross Profit 162.4B 71.92%
Operating Income 59.8B 26.49%
Net Income 46.7B 20.70%
EPS (Diluted) ₹44.97

Balance Sheet Metrics

Total Assets 372.0B
Total Liabilities 108.4B
Shareholders Equity 263.6B
Debt to Equity 0.41

Cash Flow Metrics

Operating Cash Flow 76.5B
Free Cash Flow 50.6B

Revenue & Profitability Trend

Zydus Lifesciences Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 225.7B 190.2B 168.8B 148.3B 141.2B
Cost of Goods Sold 63.4B 65.0B 65.6B 58.2B 50.7B
Gross Profit 162.4B 125.2B 103.2B 90.1B 90.5B
Operating Expenses 63.3B 45.8B 43.1B 36.4B 36.1B
Operating Income 59.8B 45.4B 28.5B 24.8B 27.4B
Pre-tax Income 60.3B 48.1B 25.9B 28.4B 24.0B
Income Tax 14.1B 9.8B 5.9B 5.1B 1.9B
Net Income 46.7B 39.7B 20.9B 46.2B 21.8B
EPS (Diluted) ₹44.97 ₹38.14 ₹19.30 ₹43.83 ₹20.84

Income Statement Trend

Zydus Lifesciences Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 170.5B 115.0B 100.2B 122.6B 87.2B
Non-Current Assets 201.6B 177.8B 157.4B 155.3B 151.7B
Total Assets 372.0B 292.8B 257.6B 278.0B 238.8B
Liabilities
Current Liabilities 90.4B 53.4B 55.3B 78.4B 78.6B
Non-Current Liabilities 18.0B 18.4B 5.4B 9.0B 10.9B
Total Liabilities 108.4B 71.8B 60.7B 87.4B 89.6B
Equity
Total Shareholders Equity 263.6B 221.0B 196.9B 190.5B 149.3B

Balance Sheet Composition

Zydus Lifesciences Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 60.3B 48.4B 25.8B 52.3B 22.8B
Operating Cash Flow 76.5B 39.7B 31.7B 24.8B 26.2B
Investing Activities
Capital Expenditures -16.6B -8.8B -9.9B -11.7B -8.5B
Investing Cash Flow -84.8B -16.0B 14.7B -11.7B -7.7B
Financing Activities
Dividends Paid -3.0B -6.2B -2.7B -3.7B -15.0M
Financing Cash Flow 20.1B -17.4B -42.8B -7.6B -13.7B
Free Cash Flow 50.6B 23.2B 16.6B 9.0B 24.4B

Cash Flow Trend

Zydus Lifesciences Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 21.63
Forward P/E 23.11
Price to Book 4.08
Price to Sales 4.21
PEG Ratio 1.21

Profitability Ratios

Profit Margin 19.47%
Operating Margin 29.52%
Return on Equity 19.28%
Return on Assets 11.24%

Financial Health

Current Ratio 1.88
Debt to Equity 12.19
Beta 0.48

Per Share Data

EPS (TTM) ₹44.95
Book Value per Share ₹238.12
Revenue per Share ₹230.95

Financial data is updated regularly. All figures are in the company's reporting currency.